CanView
CanView is an Australian digital health platform that connects prescribers, pharmacists, and patients for prescribing, ordering, and medication management of natural therapeutics and smoking cessation products, operating as a free platform with wholesale distribution via BHC under parent Vitura Health.
- Company typePrivate
- Founded2020
- HeadquartersBurleigh, Australia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What CanView does
CanView is an Australian digital health platform that facilitates prescribing, ordering, and medication management for natural therapeutics (plant-based medicine, including medicinal cannabis) and smoking cessation products. The platform serves three core user types: medical prescribers (doctors who register with AHPRA verification), pharmacists (who order wholesale products), and patients (who manage prescriptions through a mobile app). The core technology is a cloud-based healthcare platform with workflow integration capabilities and machine learning support, featuring automated TGA SAS lodgements and approval management, integrated dispensing and order management, and transparent patient prescription management. CanView aggregates Australia's widest range of natural therapeutics, listing over 350 products from 40+ suppliers including major brands such as Tilray, Little Green Pharma, Beacon Medical, ANTG, Tasmanian Botanics, and Cannatrek.
The platform operates as a B2B2C distribution model. CanView is a facilitation agent for Burleigh Heads Cannabis Pty Ltd (BHC), which is the licensed wholesaler conducting product distribution. The platform itself is free for all user types (prescribers, pharmacists, and patients), with revenue generated through transaction fees on wholesale product sales distributed via BHC. Payment terms are 14 days from invoice receipt, with extended terms available for high-volume customers. The go-to-market motion is sales-led with strong education and content marketing, including the Confident Prescriber Course and Confident Dispensing Course, which double as onboarding mechanisms providing platform access upon completion.
CanView is a wholly-owned subsidiary of Vitura Health Limited (ASX:VIT), an Australian publicly listed digital health company focused on alternative therapies. Vitura's broader portfolio includes BHC (wholesale distribution), Candor Medical (alternative therapy consultations and prescriptions), and Cortexa (psychedelics, a partnership with PharmAla Biotech). CanView was launched in 2020 and is headquartered in Burleigh, Queensland, with operations limited to the Australian market.
CanView firmographics
Firmographics- Name
- CanView
- Legal name
- Canview Pty Ltd ACN 636 679 224
- Website
- https://canview.com.au
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CanView is an Australian digital health platform that connects prescribers, pharmacists, and patients for prescribing, ordering, and medication management of natural therapeutics and smoking cessation products, operating as a free platform with wholesale distribution via BHC under parent Vitura Health.
- Ownership category
- akta.pro rank
CanView industry classification
Industry- Product category
- Digital Health Prescribing & Pharmacy Platform
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)
Keywords
Where CanView is headquartered
LocationHeadquarters
- HQ city
- Burleigh
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
CanView business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Wholesale Product Distribution: Canview acts as a facilitation agent for wholesaler BHC (Burleigh Heads Cannabis Pty Ltd). Revenue is generated through product sales to pharmacies, with transactional ordering through the platform. Payment terms include 14 days from receipt of invoice, with extended terms for customers exceeding $5001 monthly order volume.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free Platform Access |
| Unit Pricing | Pay-as-you-go | Wholesale Product Pricing |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
CanView product offering
Product offeringCore offering
CanView provides a free cloud-based prescribing, ordering and medication management platform that connects prescribers, pharmacists, suppliers and patients across Australia for alternative therapeutics and smoking cessation products. The platform centralises automated TGA lodgements, supplier selection from a catalogue of 350+ products, prescription management, and education, while CanView itself operates as a facilitation agent for wholesaler BHC (Burleigh Heads Cannabis Pty Ltd) to drive product distribution to pharmacies.
Product overview
CanView is a digital health platform offering a comprehensive ecosystem for prescribing, ordering, and managing natural therapeutics and smoking cessation products. The core CanView Platform serves as the central hub, complemented by the CanView Patient App for prescription management. Educational offerings include the Confident Prescriber Course and Confident Dispensing Course through the Education Hub. The platform facilitates access to over 40 supplier brands including Beacon Medical, ANTG, Little Green Pharma, and others, as well as smoking cessation products through brands like Bay Pharma and WILD by Instinct. CanView operates as a facilitation agent for wholesaler BHC under parent company Vitura Health.
Differentiator
Problem solved
Functional benefit
Products and services
- CanView Platform Free cloud-based digital health platform for prescribers, pharmacists and patients to prescribe, order and manage natural therapeutics and smoking cessation products with automated TGA lodgements and a catalogue of 350+ products from Australian and international suppliers.
- CanView Patient App Mobile application enabling patients to manage their prescriptions end-to-end, from ordering scripts through to delivery tracking, anywhere and anytime.
- Confident Prescriber Course Free 2.5-hour, 6-module online training equipping prescribers with skills to navigate the natural therapy landscape including the endocannabinoid system, administration routes, dosing and TGA SAS application processes; course completion provides dual login to the CanView platform.
- Confident Dispensing Course Free 2-hour, 4-module training programme preparing pharmacists to dispense natural therapeutics, covering pharmacy preparation, compliance, business operations and growth strategies; course completion provides dual login to the CanView platform.
- CanView Education Hub Central knowledge platform providing healthcare professionals with access to alternative therapy education, clinical resources, CPD-accredited webinars and educational videos including smoking cessation education.
- WILD by Instinct (Smoking Cessation Vaping Range) Regulated open and closed-system vaping products from from the fields pharmaceuticals distributed through CanView, featuring pharmacokinetically informed formulations and consistent aerosol performance for adult smoking cessation pathways.
- Bay Pharma Smoking Cessation Products Pharmaceutical-grade therapeutic vaping solutions supplied exclusively through CanView, with full TGO-110 compliance, designed to support smoking cessation and harm reduction.
Quantifiable outcome
- Supplier experienced 800% surge in product demand during 4-week launch promotion
Companies that use CanView
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
CanView technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
CanView partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- BHC (Burleigh Heads Cannabis Pty Ltd)coreCanview serves as a facilitation agent for BHC, one of Australia's largest alternative therapy wholesalers. BHC holds importation and wholesale licenses (since 2017) and sells thousands of products monthly to pharmacies. BHC partners with domestic and international suppliers for the widest product range.
- CDA ClinicsminorReferral pathway for patients seeking alternative therapy prescriptions. Canview directs patients to CDA Clinics for prescribing consultations.
- Vitura Health Limited (ASX:VIT)coreVitura Health is Canview's parent company and the largest distributor of natural therapeutics in Australia. Vitura provides the operational infrastructure including supply chain solutions, sales teams, quality assurance, and marketing support. Canview serves as the digital gateway within Vitura's portfolio of companies.
- Candor MedicalminorCandor specializes in alternative therapies consultations and prescriptions, connecting products directly with experienced alternative healthcare providers who consult with patients across Australia. Part of the Vitura ecosystem.
- Beacon Medical AustraliacoreWholly-owned subsidiary of Canadian TSX-listed Medipharm Labs (VIVO). Provides pharmaceutical-grade alternative therapies through GMP production facilities. Offers comprehensive product range tailored to different patient needs with expert guidance on prescribing and dosing.
- Australian Natural Therapeutics Group (ANTG)coreAustralian-owned company advancing medicinal cannabis through proprietary genetics, GACP/GMP-certified operations and evidence-backed research. First and only Australian alternative medicine company to receive GMP and GACP accreditations.
- Stanley BrotherscoreUS-based company focused on holistic wellness and natural therapies. Founded 2009 with mission to redefine potential of natural therapies. Supplies exclusively to Canview in Australia.
- Tasmanian BotanicscoreTasmanian-based alternative therapy company with vision to develop world-leading research, cultivation and manufacturing pharmaceutical facility. All activities at TGA-accredited GMP facility near Hobart. Committed to evidence-based approach.
- Little Green Pharma (ASX:LGP)coreAustralian company assisting patients since 2018 with locally manufactured, AU GMP-certified alternative therapies. Stands behind 'Made in Australia' stamp with strict quality requirements.
- Tilray (NASDAQ:TLRY)coreGlobal GMP-certified producer established 2013, first to legally export from North America to Australia and NZ. Leading provider in ANZ region for commercial, compassionate access and research purposes.
- CannatrekcoreAustralian-owned company founded 2015 specializing in research, cultivation, manufacturing and delivery of alternative therapy. Unique seed-to-patient model with strategic global partnerships and eight different strains.
- Bay PharmaminorFounded 2022, Sydney-based supplier of pharmaceutical-grade smoking cessation devices. Committed to Australia's transition to smoke-free future through therapeutic vaping solutions. Supplies exclusively to Canview.
- from the fieldsminorIndependent Australian sponsor of therapeutic vaping products founded 2021, Adelaide SA. Focused on supporting smoking cessation for adult smokers through WILD by Instinct brand. Supplies exclusively to Canview.
- FoliuMedcoreProduces pharmaceutical-grade alternative therapies at Colombian cultivation site with EU-GMP certified processing in Germany. Focuses on large-scale cultivation and oral dosage formats including extracts, capsules and sprays.
- CortexaminorPartnership between PharmAla Biotech (Canadian psychedelics company) and Vitura Health. Pioneering organization providing validated psychedelics for patient use, dedicated to compliance and ethical standards.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
CanView competitors and assessment
Company assessmentDirect peers
- Lyphe Australia: Australian medicinal cannabis telehealth clinic and pharmacy network that connects patients with prescribers and dispenses product. Directly comparable to CanView's combined clinical-prescribing and dispensing-platform model.
- Althea Group Holdings: Australian medicinal cannabis producer and distributor with education-focused prescriber engagement. Comparable to CanView's combined supplier-side product offering and prescriber education/ordering workflow.
- Montu: Australia's largest medicinal cannabis patient and clinic platform, offering end-to-end prescribing, pharmacy dispensing and product distribution. Directly comparable to CanView's prescribing/ordering/dispensing workflow plus B2B2C distribution model.
- Polln: Australian medicinal cannabis e-commerce/prescription platform facilitating online patient ordering and pharmacy dispensing. Comparable to CanView's patient-app-driven prescription management and direct delivery workflow.
- CDA Clinics: Australian network of clinics specializing in alternative therapy prescribing, already a referral partner of CanView. Directly comparable as a channel connecting prescribers with medicinal cannabis products in Australia.
- Cannvalate: Australian medicinal cannabis company operating across clinics, distribution and pharmacy services. Comparable to CanView as a vertically integrated prescriber-distributor in the same Australian natural therapeutics market.
- Candor Medical: Sister company within the Vitura Health ecosystem, providing alternative therapy consultations and prescriptions. Comparable to CanView as a prescriber-side channel, though operating in the same corporate group rather than purely external.
Emerging players
- Little Green Pharma: Australian GMP-certified medicinal cannabis producer with a direct supplier relationship with CanView. Comparable as a domestic producer-distributor that overlaps on the supply side and increasingly on distribution to Australian pharmacies.
- ECS Healthcare: Australian medicinal cannabis clinic and prescription platform operating as a prescriber-side channel. Comparable to CanView as an emerging player in the same prescriber-driven natural therapeutics category.
Broad incumbents
- Tilray Brands: Global GMP-certified cannabis producer with established ANZ distribution and a supplier relationship with CanView. Comparable as a broad incumbent that overlaps with CanView's distribution and supplier roles but at much larger scale and global scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
CanView social profiles
Digital presenceCanView financial estimates
Financial estimateRevenue estimate
Valuation estimate
CanView leadership team
Management profileNumber of profiles
CanView funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CanView M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CanView
What does CanView do?
CanView provides a free cloud-based prescribing, ordering and medication management platform that connects prescribers, pharmacists, suppliers and patients across Australia for alternative therapeutics and smoking cessation products. The platform centralises automated TGA lodgements, supplier selection from a catalogue of 350+ products, prescription management, and education, while CanView itself operates as a facilitation agent for wholesaler BHC (Burleigh Heads Cannabis Pty Ltd) to drive product distribution to pharmacies.
Is CanView a public or private company?
CanView is a private company. It is classified as corporate owned and is currently operating.
When was CanView founded?
CanView was founded in 2020. It employs 11 to 50 people.
Where is CanView based?
CanView is headquartered in Burleigh, Australia, in the Oceania region.
How does CanView make money?
One revenue line is on record: wholesale Product Distribution.
Who are CanView's main competitors?
Direct peers on record are Lyphe Australia, Althea Group Holdings, Montu, Polln, CDA Clinics, Cannvalate and Candor Medical. Emerging players are Little Green Pharma and ECS Healthcare. Tilray Brands is listed as a broad incumbent.
Does CanView have an API?
No public API is recorded for CanView.
What industry is CanView in?
CanView's product category is Digital Health Prescribing & Pharmacy Platform. Its primary akta.pro industry code is CRAOAHAK, Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops). Its NAICS code is 42421 and its SIC code is 5122.